 |
FILE PHOTO. © Reuters / Yara Nardi |
Source (RT.com)
The National Research Council of Canada (NRC) has struck a deal with a Chinese biotechnology company developing one of the “most advanced” vaccine candidates against the novel coronavirus to produce and test in Canada.
A vaccine named Ad5-nCoV, which may prove effective against Covid-19, has been developed by China’s CanSino Biologics company together with the Beijing Institute of Biotechnology, part of the Chinese Academy of Military Medical Sciences. It was already approved for the first phase of clinical trials in China in mid-March and is now expected to be tested in Canada too.(READ MORE)
No comments:
Post a Comment